Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: April 28, 2025
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 24, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
Journal: NPJ breast cancer
Published: August 17, 2022
Overall survival is the lowest among young women with postpartum breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 15, 2021
Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.
Journal: Current breast cancer reports
Published: August 30, 2021
Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2.
Journal: Molecular cancer therapeutics
Published: January 29, 2021
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval.
Journal: Breast cancer research and treatment
Published: October 07, 2020
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Journal: Breast cancer research and treatment
Published: December 20, 2018
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Journal: Breast cancer research and treatment
Published: December 20, 2018
Last Updated: 09/26/2026